財務情報
- Market Capitalization 1.17 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-16.18
売上高対価格比率
179.93
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2282 | ORIC Oric Pharmaceuticals, Inc. - Common Stock | 11.31 USD | -4.23% | -4.40% | -10.24% | -16.28% | 1.17 B USD | ||
| 2284 | GHRS GH Research PLC - Ordinary Shares | 18.85 USD | -5.84% | -11.87% | -31.78% | +33.12% | 1.17 B USD | ||
| 2299 | BCAX Bicara Therapeutics Inc. - Common Stock | 17.34 USD | +0.06% | +5.47% | -24.97% | +20.08% | 1.15 B USD | ||
| 2303 | REPL Replimune Group, Inc. - Common Stock | 12.11 USD | -7.35% | -7.84% | -6.70% | +177.75% | 1.14 B USD |